0001752724-24-053397.txt : 20240313 0001752724-24-053397.hdr.sgml : 20240313 20240313125337 ACCESSION NUMBER: 0001752724-24-053397 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 EFFECTIVENESS DATE: 20240313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alger ETF Trust CENTRAL INDEX KEY: 0001807486 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-23603 FILM NUMBER: 24745266 BUSINESS ADDRESS: STREET 1: 100 PEARL STREET STREET 2: 27TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 BUSINESS PHONE: 212-806-8833 MAIL ADDRESS: STREET 1: 100 PEARL STREET STREET 2: 27TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 0001807486 S000069955 Alger Mid Cap 40 ETF C000222788 Alger Mid Cap 40 ETF FRTY 0001807486 S000069956 Alger 35 ETF C000222789 Alger 35 ETF ATFV 0001807486 S000079631 Alger Weatherbie Enduring Growth ETF C000240821 Alger Weatherbie Enduring Growth ETF AWEG 0001807486 S000084280 Alger Concentrated Equity ETF C000248577 Alger Concentrated Equity ETF 0001807486 S000084281 Alger Artificial Intelligence ETF C000248578 Alger Artificial Intelligence ETF N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0001807486 XXXXXXXX 811-23603 true false false N-1A true Alger ETF Trust 811-23603 0001807486 5493001LMS20X4PV3S52 100 Pearl Street New York 10004-6030 US-NY US (800) 223-3810 Fred Alger & Company, LLC 100 Pearl Street New York 10004-6030 212-806-8800 Records related to its functions as distributor BROWN BROTHERS HARRIMAN & CO. 50 Post Office Square Boston 02110-1548 617-772-1818 Records related to its functions as custodian, accounting agent and transfer agent Fred Alger Management, LLC 100 Pearl Street New York 10004-6030 212-806-8800 Records related to its functions as advisor, administrator, and shareholder servicing agent Weatherbie Capital, LLC 265 Franklin Street Boston 02110-3158 617-951-2550 Records related to its functions as sub-advisor N N N-1A 3 Y Charles F. Baird N/A N Nathan E. Saint-Amand M.D. N/A N Hilary M. Alger 001164468 Y David Rosenberg N/A N Tina Payne 005391957 100 Pearl Street New York 10004-6030 XXXXXX N N N N N N Fred Alger & Company, LLC 008-15900 000005300 549300RNUBAZ7ALEZI84 Y N Deloitte & Touche LLP 34 549300FJV7IV1ZHGAV28 N N N N N N N Alger 35 ETF S000069956 549300XPINPN13F35A88 N 1 0 0 Exchange-Traded Fund Y N Y N N/A 0.00000000 0.00000000 Rule 18f-4 (17 CFR 270.18f-4) Rule 32a-4 (17 CFR 270.32a-4) Rule 17e-1 (17 CFR 270.17e-1) Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) Y Y Y N Fred Alger Management, LLC 801-6709 000106750 549300TITGLG7BXCGB39 N Brown Brothers Harriman & Co. 084-06072 5493006KMX1VFTPYPW14 N N N Refinitiv US LLC 213800HQORQAP68CJJ04 N N BROWN BROTHERS HARRIMAN AND CO 5493006KMX1VFTPYPW14 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Fred Alger Management, LLC 549300TITGLG7BXCGB39 Y N N Fred Alger Management, LLC 549300TITGLG7BXCGB39 Y N Brown Brothers Harriman & Co. 5493006KMX1VFTPYPW14 N Y N Fred Alger & Company, LLC 008-15900 000005300 549300RNUBAZ7ALEZI84 7887.11000000 Bay Crest Partners, LLC 008-48931 000039944 549300CTRRO8C3BU3H64 3215.57000000 LPS CAPITAL LLC 008-68706 000155246 54930066TNBSV20OYC83 1753.15000000 BTIG, LLC 008-65473 000122225 549300GTG9PL6WO3EC51 1549.54000000 ABEL NOSER, L.L.C. 008-69809 000284714 549300UQY3DBDP2Y2N55 3478.81000000 STIFEL, NICOLAUS & COMPANY, INCORPORATED 008-01447 000000793 5WUVMA08EYG4KEUPW589 2537.42000000 Jefferies LLC 008-15074 000002347 58PU97L1C0WSRCWADL48 2064.17000000 PIPER JAFFRAY & CO. 08-15204 000000665 549300GRQCWQ3XGH0H10 8346.42000000 CANACCORD GENUITY WEALTH MANAGEMENT (USA) INC. 008-21025 000007749 549300Y8YMXR5LZ07B04 CA 5141.97000000 Fred Alger & Company, LLC 008-15900 000005300 549300RNUBAZ7ALEZI84 7887.11000000 Wells Fargo Securities LLC 008-65876 000126292 VYVVCKR63DVZZN70PB21 8389.39000000 59322.80000000 0.00000000 Y 11262773.26000000 N N N Alger Mid Cap 40 ETF S000069955 549300BGEV4QVML5IV31 N 1 0 0 Exchange-Traded Fund Y N Y N N/A 0.00000000 0.00000000 Rule 17e-1 (17 CFR 270.17e-1) Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) Rule 18f-4 (17 CFR 270.18f-4) Rule 32a-4 (17 CFR 270.32a-4) Y Y Y N Fred Alger Management, LLC 801-6709 000106750 549300TITGLG7BXCGB39 N Brown Brothers Harriman & Co. 084-06072 5493006KMX1VFTPYPW14 N N N Refinitiv US LLC 213800HQORQAP68CJJ04 N N BROWN BROTHERS HARRIMAN AND CO 5493006KMX1VFTPYPW14 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N Fred Alger Management, LLC 549300TITGLG7BXCGB39 Y N N Fred Alger Management, LLC 549300TITGLG7BXCGB39 Y N Brown Brothers Harriman & Co. 5493006KMX1VFTPYPW14 N Y N Fred Alger & Company, LLC 008-15900 000005300 549300RNUBAZ7ALEZI84 6733.40000000 OPPENHEIMER & CO. INC. 008-04077 000000249 254900VH02JQR2L8XD64 4542.22000000 Wells Fargo Securities LLC 008-65876 000126292 VYVVCKR63DVZZN70PB21 5068.11000000 BERENBERG BANK Stiftung von 1990 N/A N/A 5299000WI2BXRB3KKL92 DE 4298.47000000 BTIG, LLC 008-65473 000122225 549300GTG9PL6WO3EC51 2136.29000000 MORGAN STANLEY & CO. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 4239.06000000 Citigroup Global Markets Inc. 008-08177 000007059 MBNUM2BPBDO7JBLYG310 2184.62000000 Fred Alger & Company, LLC 008-15900 000005300 549300RNUBAZ7ALEZI84 6733.40000000 Bay Crest Partners, LLC 008-48931 000039944 549300CTRRO8C3BU3H64 3791.90000000 PIPER JAFFRAY & CO. 08-15204 000000665 549300GRQCWQ3XGH0H10 9388.39000000 CANACCORD GENUITY WEALTH MANAGEMENT (USA) INC. 008-21025 000007749 549300Y8YMXR5LZ07B04 CA 6603.76000000 75836.28000000 Citigroup Global Markets Inc. 008-08177 000007059 MBNUM2BPBDO7JBLYG310 44820.00000000 Goldman Sachs & Co, LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 423276.00000000 STIFEL, NICOLAUS & COMPANY, INCORPORATED 008-01447 000000793 5WUVMA08EYG4KEUPW589 1998424.02000000 2466520.02000000 Y 27603059.44000000 N N N Alger Weatherbie Enduring Growth ETF S000079631 549300KIDNFBXODQU524 Y 1 1 0 Exchange-Traded Fund Y N Y N N/A 0.00000000 0.00000000 Rule 18f-4 (17 CFR 270.18f-4) Rule 17e-1 (17 CFR 270.17e-1) Rule 32a-4 (17 CFR 270.32a-4) Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) Y Y Y N Fred Alger Management, LLC 801-6709 000106750 549300TITGLG7BXCGB39 N Weatherbie Capital, LLC 801-50672 000105991 N/A Y Brown Brothers Harriman & Co. 084-06072 5493006KMX1VFTPYPW14 N N N Refinitiv US LLC 213800HQORQAP68CJJ04 N N BROWN BROTHERS HARRIMAN AND CO 5493006KMX1VFTPYPW14 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) EUROCLEAR BANK SA NV 549300OZ46BRLZ8Y6F65 BE N Y Foreign securities depository - rule 17f-7 (17 CFR 270.17f-7) N Fred Alger Management, LLC 549300TITGLG7BXCGB39 Y N N Brown Brothers Harriman & Co. 5493006KMX1VFTPYPW14 N Y Fred Alger Management, LLC 549300TITGLG7BXCGB39 Y N N Fred Alger & Company, LLC 008-15900 000005300 549300RNUBAZ7ALEZI84 0.00000000 CANACCORD GENUITY WEALTH MANAGEMENT (USA) INC. 008-21025 000007749 549300Y8YMXR5LZ07B04 CA 142.81000000 COWEN AND COMPANY, LLC 008-22522 000007616 549300WR155U7DVMIW58 144.94000000 ROYAL BANK OF CANADA N/A N/A ES7IP3U3RHIGC71XBU11 CA 218.78000000 Needham & Company, LLC 008-33772 000016360 254900J2GFQ4J4NK1J89 60.63000000 Virtu Americas LLC 008-68193 000149823 549300RA02N3BNSWBV74 652.85000000 LIQUIDNET INC. 008-52461 000103987 213800HSKBBO1GCVRG79 89.62000000 RAYMOND JAMES (USA) LTD. 008-42071 000025853 9845000D4AB6D9B2AA23 CA 113.94000000 Goldman Sachs & Co, LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 45.82000000 OPPENHEIMER & CO. INC. 008-04077 000000249 254900VH02JQR2L8XD64 165.70000000 MERRILL LYNCH, PIERCE, FENNER & SMITH INC. 008-07221 000007691 8NAV47T0Y26Q87Y0QP81 271.41000000 2078.45000000 0.00000000 Y 3643124.88000000 N N N Alger 35 ETF S000069956 N 12500.00000000 2.40433058 3.35320095 97.59566942 3.35320095 6.41852182 0.79084226 93.58147818 0.79084226 0.00000000 100.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 50.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N Alger Mid Cap 40 ETF S000069955 N 12500.00000000 6.50986428 1.64095280 93.49013572 1.64095280 7.89553579 2.02912528 92.10446421 2.02912528 0.00000000 160.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 160.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N Alger Weatherbie Enduring Growth ETF S000079631 N 12500.00000000 7.77582460 1.23048758 92.22417540 1.23048758 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 133.33333333 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 N false false true false false false INTERNAL CONTROL RPT 2 Alger_ETF_Trust.txt AUDITOR'S LETTER REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Shareholders of Alger 35 ETF, Alger Mid Cap 40 ETF and Alger Weatherbie Enduring Growth ETF and the Board of Trustees of The Alger ETF Trust: In planning and performing our audits of the financial statements of The Alger ETF Trust (the "Trust"), including Alger 35 ETF, Alger Mid Cap 40 ETF and Alger Weatherbie Enduring Growth ETF, as of and for the period or year ended December 31, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Trust's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Trust's internal control over financial reporting. Accordingly, we express no such opinion. The management of the Trust is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A trust's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A trust's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the trust; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the trust are being made only in accordance with authorizations of management and directors of the trust; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of a trust's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the trust's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Trust's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Trust's internal control over financial reporting and its operation, including controls for safeguarding securities, that we consider to be a material weakness, as defined above, as of December 31, 2023. This report is intended solely for the information and use of management and the Board of Trustees of the Trust and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. Deloitte & Touche LLP New York, New York February 26, 2024